Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 166, Issue 2, 2006, Pages 152-156

  Stockero, Kimberly J ^a   Fink, Stephanie R ^a   Smoley, Stephanie A ^a   Paternoster, Sarah F ^a   Shanafelt, Tait D ^b   Call, Timothy G ^b   Zent, Clive S ^b   Van Dyke, Daniel L ^a   Kay, Neil E ^b   Dewald, Gordon W ^a  

^a Genzyme Genetics   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHROMOSOME 13Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 13; CHROMOSOME G BAND; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; INTERSTITIAL CHROMOSOME DELETION; MALE; METAPHASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; COHORT STUDIES; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, B-CELL, CHRONIC; MALE; METAPHASE; MIDDLE AGED;

EID: 33646035528     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.10.011     Document Type: Article

References (21)

1. Dewald G.W., Wyatt W.A., and Silver R.T. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. Leuk Lymphoma 34 (1999) 481-491
2. Dewald G.W., Wyatt W.A., Juneau A.L., Carlson R.O., Zinsmeister A.R., Jalal S.M., Spurbeck J.L., and Silver R.T. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 91 (1998) 3357-3365
3. Pardanani A., Brockman S.R., Paternoster S.F., Flynn H.C., Ketterling R.P., Lasho T.L., Ho C.L., Li C.Y., Dewald G.W., and Tefferi A. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 104 (2004) 3038-3045
4. Dewald G.W., Brockman S.R., Paternoster S.F., Bone N.D., O'Fallon J.R., Allmer C., James C.D., Jelinek D.F., Tschumper R.C., Hanson C.A., Pruthi R.K., Witzig T.E., Call T.G., and Kay N.E. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 121 (2003) 287-295
5. Fink S.R., Paternoster S.F., Smoley S.A., Flynn H.C., Geyer S.M., Shanafelt T.D., Lee Y.K., Jelinek D.F., Kay N.E., and Dewald G.W. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leuk Res 29 (2005) 253-262
6. Goorha S., Glenn M.J., Drozd-Borysiuk E., and Chen Z. A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genet Med 6 (2004) 48-53
7. In: Mitelman F. (Ed). An International System for Human Cytogenetic Nomenclature (1995), S. Karger, Basel, Switzerland
8. Mayr C., Speicher M.R., Kofler D.M., Buhmann R., Strehl J., Busch R., Hallek M., and Wendtner C.M. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107 (2006) 742-751
9. Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., Parker A.C., Castoldi G.L., Guneo A., Knuutila S., Elonen E., and Gahrton G. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323 (1990) 720-724
10. Borgstrom G.H., Knuutila S., Ruutu T., Pakkala A., Lahtinen R., and de la Chapelle A. Abnormalities of chromosome 13 in myelofibrosis. Scand J Haematol 33 (1984) 15-21
11. Demory J.L., Dupriez B., Fenaux P., Lai J.L., Beuscart R., Jouet J.P., Deminatti M., and Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood 72 (1988) 855-859
12. Rege-Cambrin G., Mecucci C., Tricot G., Michaux J.L., Louwagie A., Van Hove W., Francart H., and Van den Berghe H. A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 25 (1987) 233-245
13. Johnson D.D., Dewald G.W., Pierre R.V., Letendre L., and Silverstein M.N. Deletions of chromosome 13 in malignant hematologic disorders. Cancer Genet Cytogenet 18 (1985) 235-241
14. Fonseca R., Oken M.M., Harrington D., Bailey R.J., Van Wier S.A., Henderson K.J., Kay N.E., Van Ness B., Greipp P.R., and Dewald G.W. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Leukemia 15 (2001) 981-986
15. Tricot G., Barlogie B., Jagannath S., Bracy D., Mattox S., Vesole D.H., Naucke S., and Sawyer J.R. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86 (1995) 4250-4256
16. Dewald G., Therneau T., Larson D., Lee Y.K., Fink S., Smoley S., Paternoster S., Adeyinka A., Ketterling R., Van Dyke D.L., Fonseca R., and Kyle R. Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood 106 (2005) 3553-3558
17. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J. (Eds). World Health Organization of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), International Agency for Research on Cancer, Lyon, France
18. Jaffe E.S., Harris N.L., Diebold J., and Muller-Hermelink H.K. World Health Organization classification of lymphomas: a work in progress. Ann Oncol 9 (1998) S25-S30
19. Messmer B.T., Messmer D., Allen S.L., Kolitz J.E., Kudalkar P., Cesar D., Murphy E.J., Koduru P., Ferrarini M., Zupo S., Cutrona G., Damle R.N., Wasil T., Rai K.R., Hellerstein M.K., and Chiorazzi N. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 15 (2005) 755-764
20. Shanafelt T.D., Geyer S.M., and Kay N.E. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 103 (2004) 1202-1210
21. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., Dohner K., Bentz M., and Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343 (2000) 1910-1916